This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Plant Health Care Valuation

Is PHC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHC (£0.09) is trading below our estimate of fair value (£0.24)

Significantly Below Fair Value: PHC is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHC?

Key metric: As PHC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PHC. This is calculated by dividing PHC's market cap by their current revenue.
What is PHC's PS Ratio?
PS Ratio	3.5x
Sales	US$11.21m
Market Cap	US$39.75m

PHC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	-8.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does PHC's PS Ratio compare to its peers?

The above table shows the PS ratio for PHC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.9x
EDEN Eden Research	5.4x	16.0%	UK£21.1m
HMI Harvest Minerals	0.9x	n/a	UK£1.6m
KRPZ Kropz	0.5x	n/a	UK£12.0m
IOF Iofina	0.9x	9.8%	UK£36.5m
PHC Plant Health Care	3.5x	35.8%	UK£30.5m

Price-To-Sales vs Peers: PHC is expensive based on its Price-To-Sales Ratio (3.5x) compared to the peer average (2.7x).

Price to Sales Ratio vs Industry

How does PHC's PS Ratio compare vs other companies in the GB Chemicals Industry?

6 Companies	Price / Sales	Estimated Growth	Market Cap
JMAT Johnson Matthey	0.2x	-32.5%	US$2.94b
SYNT Synthomer	0.1x	5.0%	US$346.82m
CAR Carclo	0.2x	7.0%	US$30.76m
HEIQ HeiQ	0.2x	n/a	US$9.61m

6 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: PHC is expensive based on its Price-To-Sales Ratio (3.5x) compared to the UK Chemicals industry average (1.7x).

Price to Sales Ratio vs Fair Ratio

What is PHC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.5x
Fair PS Ratio	6.3x

Price-To-Sales vs Fair Ratio: PHC is good value based on its Price-To-Sales Ratio (3.5x) compared to the estimated Fair Price-To-Sales Ratio (6.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

TFF Group

€626.6m

Manufactures and distributes barrels and wood products for the aging of wines and alcohols in France, rest of Europe, the United States, Asia, and internationally.

0IH4

€29.10

-6.7%

-31.7%

NV Bekaert

€1.7b

Provides steel wire transformation and coating technologies worldwide.

0OQJ

€32.88

1.8%

-24.1%

Elkem

NOK 11.7b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 18.39

1.8%

4.5%